Using genetic tests to guide treatment for suspected sepsis
Part of Infections clinical trials.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Doctors suspect you have an infection, or you have been started on a sepsis pathway within 24 hours of arriving at the hospital.
- If the hospital's alert system flags you for sepsis, you must also have low blood pressure or high blood lactate (a sign of severe infection) and at least two signs of inflammation (like fever, fast heart rate, fast breathing, or abnormal white blood cell count).
- You do not have a 'Do Not Resuscitate' (DNR) or 'Do Not Intubate' (DNI) order.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
This trial is testing a new tool that uses artificial intelligence and biomarkers (substances in your blood) to help doctors recognize sepsis earlier. If you have been diagnosed with sepsis or are suspected of having it, this study may help improve how quickly and accurately it's detected.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.